| Metrics | Details |
|---|---|
| Years | 2020-2035 |
| Base Year | 2025 |
| Market Size | 3100 |
| Regions | Germany, France, UK, Italy, Spain, Netherlands, Poland, Belgium, Denmark, Sweden, Ukraine, Russia, Rest of Europe |
| Segments | Biomarker-based Screening, Imaging-based Screening, Liquid Biopsy, Molecular Diagnostics, Immunoassay, Others, Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Others |
| Players | Roche, Siemens Healthineers, Illumina, Thermo Fisher Scientific, Abbott Laboratories, Qiagen, GE Healthcare, Agilent Technologies, BD, Bio-Rad Laboratories, Hologic Inc., Danaher Corporation, Myriad Genetics, Guardant Health, Epigenomics AG |
How Will You Befit From our consulting service
